300298 三诺生物
已收盘 01-07 15:00:00
资讯
新帖
简况
三诺生物（300298）披露关于预计触发可转债转股价格向下修正条件的提示性公告，1月7日股价下跌1.41%
证券之星 · 17:36
三诺生物（300298）披露关于预计触发可转债转股价格向下修正条件的提示性公告，1月7日股价下跌1.41%
股市必读：三诺生物（300298）1月6日董秘有最新回复
证券之星 · 01:22
股市必读：三诺生物（300298）1月6日董秘有最新回复
股市必读：三诺生物（300298）12月31日董秘有最新回复
证券之星 · 01-05 04:13
股市必读：三诺生物（300298）12月31日董秘有最新回复
三诺生物：董事会完成换届选举，李少波当选董事长，李心一任副董事长兼总经理
财经网 · 01-04
三诺生物：董事会完成换届选举，李少波当选董事长，李心一任副董事长兼总经理
每周股票复盘：三诺生物（300298）完成董事会换届选举
证券之星 · 01-03
每周股票复盘：三诺生物（300298）完成董事会换届选举
三诺生物：CGM二代产品销售规模稳步增长
证券之星 · 2025-12-31
三诺生物：CGM二代产品销售规模稳步增长
三诺生物将召开临时股东会审议多项议案，涉及章程修订、董事会换届及续聘审计机构等
中金财经 · 2025-12-26
三诺生物将召开临时股东会审议多项议案，涉及章程修订、董事会换届及续聘审计机构等
三诺生物（300298）披露取得医疗器械注册证，12月24日股价上涨0.71%
证券之星 · 2025-12-24
三诺生物（300298）披露取得医疗器械注册证，12月24日股价上涨0.71%
三诺生物：是蚂蚁阿福首批健康管理设备合作伙伴之一
证券之星 · 2025-12-22
三诺生物：是蚂蚁阿福首批健康管理设备合作伙伴之一
12月18日三诺生物涨6.47%，太平丰盈一年定开债券发起式基金重仓该股
证券之星 · 2025-12-18
12月18日三诺生物涨6.47%，太平丰盈一年定开债券发起式基金重仓该股
三诺生物传感股份有限公司修订董事及高管持股管理制度，强化股份变动规范
中金财经 · 2025-12-16
三诺生物传感股份有限公司修订董事及高管持股管理制度，强化股份变动规范
三诺生物拟续聘信永中和为2025年度审计机构
中金财经 · 2025-12-16
三诺生物拟续聘信永中和为2025年度审计机构
三诺生物控股股东李少波补充质押300万股股份
中金财经 · 2025-12-15
三诺生物控股股东李少波补充质押300万股股份
三诺生物传感股份有限公司关于“三诺转债”2025年度付息公告
中金财经 · 2025-12-15
三诺生物传感股份有限公司关于“三诺转债”2025年度付息公告
三诺生物：不向下修正转股价格
证券之星 · 2025-12-10
三诺生物：不向下修正转股价格
三诺生物：公司将积极拓展境内外业务布局
证券日报网 · 2025-12-08
三诺生物：公司将积极拓展境内外业务布局
三诺生物：海牙法院批准雅培一项临时禁令
证券之星 · 2025-12-08
三诺生物：海牙法院批准雅培一项临时禁令
三诺生物：第二代CGM产品获欧盟MDR认证
证券之星 · 2025-12-08
三诺生物：第二代CGM产品获欧盟MDR认证
三诺生物（300298）披露关于回购公司部分股份的进展公告，12月02日股价下跌0.73%
证券之星 · 2025-12-02
三诺生物（300298）披露关于回购公司部分股份的进展公告，12月02日股价下跌0.73%
三诺生物为控股子公司心诺健康提供4300万元贷款担保
中金财经 · 2025-12-02
三诺生物为控股子公司心诺健康提供4300万元贷款担保
加载更多
公司概况
公司名称：
三诺生物传感股份有限公司
所属行业：
专用设备制造业
上市日期：
2012-03-19
主营业务：
三诺生物传感股份有限公司的主营业务是血糖监测系统的生产和销售。公司的主要产品是血糖监测系统。公司作为血糖监测领域领先企业，相继获得国内外权威机构的高度认可和荣誉。荣获“国家企业技术中心”、“国家工程研究中心”、“国家技术创新示范企业”、“国家知识产权优势企业”、“国家科技进步二等奖”和“国家绿色工厂”等资质。
发行价格：
29.00
{"stockData":{"symbol":"300298","market":"SZ","secType":"STK","nameCN":"三诺生物","latestPrice":17.47,"timestamp":1767769401000,"preClose":17.72,"halted":0,"volume":6603200,"delay":0,"changeRate":-0.0141,"floatShares":451000000,"shares":560000000,"eps":0.5033,"marketStatus":"已收盘","change":-0.25,"latestTime":"01-07 15:00:00","open":17.69,"high":17.72,"low":17.45,"amount":116000000,"amplitude":0.0152,"askPrice":17.47,"askSize":55,"bidPrice":17.46,"bidSize":311,"shortable":0,"etf":0,"ttmEps":0.5033,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767835800000},"marketStatusCode":5,"adr":0,"adjPreClose":17.72,"symbolType":"stock","openAndCloseTimeList":[[1767749400000,1767756600000],[1767762000000,1767769200000]],"highLimit":19.49,"lowLimit":15.95,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":560267306,"isCdr":false,"pbRate":3.11,"roa":"--","peRate":34.710908,"roe":"6.28%","epsLYR":0.589,"committee":0.570567,"marketValue":9788000000,"turnoverRate":0.0146,"status":1,"floatMarketCap":7884000000},"requestUrl":"/m/hq/s/300298","defaultTab":"news","newsList":[{"id":"2601879872","title":"三诺生物（300298）披露关于预计触发可转债转股价格向下修正条件的提示性公告，1月7日股价下跌1.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601879872","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601879872?lang=zh_cn&edition=full","pubTime":"2026-01-07 17:36","pubTimestamp":1767778592,"startTime":"0","endTime":"0","summary":"截至2026年1月7日收盘，三诺生物报收于17.47元，较前一交易日下跌1.41%，最新总市值为97.88亿元。该股当日开盘17.69元，最高17.72元，最低17.45元，成交额达1.16亿元，换手率为1.46%。公司近日发布公告称，自2025年12月22日至2026年1月6日，公司股票已有10个交易日收盘价低于当期转股价格34.46元/股的80%，预计将触发“三诺转债”转股价格向下修正条件。若后续触发修正条款，董事会将有权提出修正方案并提交股东大会表决。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700027296.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","300298","BK0251","BK0102"],"gpt_icon":0},{"id":"2601814398","title":"股市必读：三诺生物（300298）1月6日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2601814398","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601814398?lang=zh_cn&edition=full","pubTime":"2026-01-07 01:22","pubTimestamp":1767720132,"startTime":"0","endTime":"0","summary":"截至2026年1月6日收盘，三诺生物报收于17.72元，上涨0.0%，换手率2.11%，成交量9.52万手，成交额1.68亿元。来自公司公告汇总：三诺生物连续10个交易日股价低于转股价格80%，预计将触发可转债转股价格向下修正条件。若后续触发修正条款，董事会将有权提出修正方案并提交股东大会表决。公司将按规定履行审议程序及信息披露义务。转股期限为2021年6月25日至2026年12月20日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700000639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300298","BK0114","BK0102","BK0251"],"gpt_icon":0},{"id":"2601024850","title":"股市必读：三诺生物（300298）12月31日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2601024850","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601024850?lang=zh_cn&edition=full","pubTime":"2026-01-05 04:13","pubTimestamp":1767557591,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，三诺生物报收于17.11元，下跌0.12%，换手率0.96%，成交量4.32万手，成交额7404.65万元。公司公告汇总北京植德律师事务所关于三诺生物传感股份有限公司2025年第一次临时股东会的法律意见书三诺生物传感股份有限公司于2025年12月31日召开2025年第一次临时股东大会，会议由董事会召集，董事长李少波主持。董事会成员共7人，含3名非独立董事、3名独立董事和1名职工代表董事。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500001378.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0114","300298","BK0102"],"gpt_icon":0},{"id":"2600049876","title":"三诺生物：董事会完成换届选举，李少波当选董事长，李心一任副董事长兼总经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2600049876","media":"财经网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600049876?lang=zh_cn&edition=full","pubTime":"2026-01-04 12:39","pubTimestamp":1767501540,"startTime":"0","endTime":"0","summary":"近日，三诺生物发布公告称，公司于近日召开临时股东大会，选举产生了公司第六届董事会成员。在新一届董事会的第一次会议上，公司聘任了新的高级管理人员和证券事务代表，任期同样为三年。公告提到，截至本公告日，李少波直接持有公司股份142,685,648股，为公司控股股东、实际控制人，李少波与公司副董事长、总经理李心一系父女关系，与持有公司5%以上有表决权股份的股东、公司其他董事、高级管理人员不存在关联关系。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-04/doc-inhfchyt2982830.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-04/doc-inhfchyt2982830.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0102","BK0114","BK0251","300298"],"gpt_icon":0},{"id":"2600894060","title":"每周股票复盘：三诺生物（300298）完成董事会换届选举","url":"https://stock-news.laohu8.com/highlight/detail?id=2600894060","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600894060?lang=zh_cn&edition=full","pubTime":"2026-01-03 03:18","pubTimestamp":1767381537,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，三诺生物报收于17.11元，较上周的17.44元下跌1.89%。本周，三诺生物12月29日盘中最高价报17.49元。本周关注点公司公告汇总：三诺生物完成第六届董事会换届选举，李少波当选董事长，李心一任副董事长兼总经理。董事会共7人，包括3名非独立董事、3名独立董事和1名职工代表董事。原部分董事、监事及高管因任期届满离任。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300002135.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0251","BK0114","300298"],"gpt_icon":0},{"id":"2595091776","title":"三诺生物：CGM二代产品销售规模稳步增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2595091776","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595091776?lang=zh_cn&edition=full","pubTime":"2025-12-31 19:51","pubTimestamp":1767181870,"startTime":"0","endTime":"0","summary":"公司 CGM 二代产品目前处于市场拓展阶段，行业内关于公司二代 CGM 产品细分市场的权威统计数据尚不够完整。公司 CGM 二代产品自上市以来，凭借高性价比与完善的终端服务体系，销售规模稳步增长，市场认可度持续提升，公司正积极拓展国内外市场。若未来有第三方专业机构发布CGM细分市场具体市场份额的权威数据，公司将结合自身情况在定期报告中予以说明。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100039988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0102","BK0114","300298"],"gpt_icon":0},{"id":"2594293038","title":"三诺生物将召开临时股东会审议多项议案，涉及章程修订、董事会换届及续聘审计机构等","url":"https://stock-news.laohu8.com/highlight/detail?id=2594293038","media":"中金财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594293038?lang=zh_cn&edition=full","pubTime":"2025-12-26 19:02","pubTimestamp":1766746920,"startTime":"0","endTime":"0","summary":"会议将审议多项重要议案，核心内容包括：修订《公司章程》并调整公司治理结构；修订和制定包括《董事会议事规则》《独立董事工作制度》在内的九项公司治理制度；续聘2025年度审计机构；以及为董事及高级管理人员购买责任险。其中，修订《公司章程》等三项议案需经出席会议股东所持表决权的三分之二以上通过，购买董监高责任险的议案关联股东需回避表决。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251226/31895355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300298","BK0102","BK0114","BK0251"],"gpt_icon":0},{"id":"2593756624","title":"三诺生物（300298）披露取得医疗器械注册证，12月24日股价上涨0.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593756624","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593756624?lang=zh_cn&edition=full","pubTime":"2025-12-24 17:52","pubTimestamp":1766569946,"startTime":"0","endTime":"0","summary":"截至2025年12月24日收盘，三诺生物报收于17.14元，较前一交易日上涨0.71%，最新总市值为96.03亿元。该股当日开盘17.02元，最高17.16元，最低16.96元，成交额达7835.09万元，换手率为1.02%。公司近日发布公告称，三诺生物传感股份有限公司近日获得湖南省药品监督管理局颁发的四项医疗器械注册证。其中，血糖尿酸血酮分析仪为新获批注册证，其余三项为延续注册。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400029162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1100","BK1574","09997","BK0114","09996","BK0102","300298","BK1222","BK0251","159883","BK1583"],"gpt_icon":0},{"id":"2593548987","title":"三诺生物：是蚂蚁阿福首批健康管理设备合作伙伴之一","url":"https://stock-news.laohu8.com/highlight/detail?id=2593548987","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593548987?lang=zh_cn&edition=full","pubTime":"2025-12-22 18:30","pubTimestamp":1766399424,"startTime":"0","endTime":"0","summary":"三诺生物是蚂蚁AQ即蚂蚁阿福的首批健康管理设备合作伙伴之一。三诺血糖管理是联合蚂蚁阿福提供的糖尿病专业智能体，基于公司多年深耕糖尿病领域的经验积累，融合持续血糖监测数据、糖尿病专业知识体系及逆转方法论，精心打造的个性化智能慢病管理服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200024271.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0102","BK0114","300298"],"gpt_icon":0},{"id":"2592697892","title":"12月18日三诺生物涨6.47%，太平丰盈一年定开债券发起式基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2592697892","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592697892?lang=zh_cn&edition=full","pubTime":"2025-12-18 15:35","pubTimestamp":1766043339,"startTime":"0","endTime":"0","summary":"证券之星消息，12月18日三诺生物涨6.47%，收盘报17.78元，换手率4.69%，成交量21.17万手，成交额3.68亿元。重仓三诺生物的公募基金请见下表：该股最近90天内共有10家机构给出评级，买入评级8家，增持评级2家；过去90天内机构目标均价为25.0。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为太平基金的太平丰盈一年定开债券发起式。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800017889.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0102","300298","BK0114"],"gpt_icon":0},{"id":"2591360689","title":"三诺生物传感股份有限公司修订董事及高管持股管理制度，强化股份变动规范","url":"https://stock-news.laohu8.com/highlight/detail?id=2591360689","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591360689?lang=zh_cn&edition=full","pubTime":"2025-12-16 14:52","pubTimestamp":1765867931,"startTime":"0","endTime":"0","summary":"中访网数据 三诺生物传感股份有限公司于近期完成了《董事、高级管理人员持有和买卖公司股票管理制度》的修订，新制度自2025年12月起生效。 此次制度修订体现了三诺生物传感股份有限公司持续完善公司治理、加强内幕信息管理、规范关键人员股份交易的决心，有助于提升公司规范运作水平，保护投资者合法权益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251216/31868593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0251","BK0102","300298","BK0114"],"gpt_icon":0},{"id":"2591049608","title":"三诺生物拟续聘信永中和为2025年度审计机构","url":"https://stock-news.laohu8.com/highlight/detail?id=2591049608","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591049608?lang=zh_cn&edition=full","pubTime":"2025-12-16 13:43","pubTimestamp":1765863804,"startTime":"0","endTime":"0","summary":"中访网数据 三诺生物传感股份有限公司于2025年12月15日召开董事会，审议通过议案，拟继续聘请信永中和会计师事务所为公司2025年度审计机构。该议案尚需提交公司2025年第一次临时股东会审议。信永中和作为国内大型会计师事务所，2024年度业务收入达40.54亿元，拥有丰富的上市公司审计经验。本次续聘符合相关监管规定，旨在保障公司年度财务报告及内部控制审计工作的质量，维护公司及全体股东的合法权益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251216/31868526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0251","BK0114","BK0102","300298"],"gpt_icon":0},{"id":"2591610525","title":"三诺生物控股股东李少波补充质押300万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2591610525","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591610525?lang=zh_cn&edition=full","pubTime":"2025-12-15 18:24","pubTimestamp":1765794288,"startTime":"0","endTime":"0","summary":"中访网数据 三诺生物传感股份有限公司于近日发布公告，公司控股股东、实际控制人李少波先生将其持有的部分公司股份办理了补充质押。本次补充质押股份数量为300万股，占其所持股份比例的2.10%，占公司总股本的0.54%。 截至公告披露日，李少波先生直接持有公司股份约1.43亿股，占总股本的25.47%；其累计质押股份数量增至7395万股，占其直接持股比例的51.83%，占公司总股本的13.20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251215/31866601.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0251","BK0102","300298","BK0114"],"gpt_icon":0},{"id":"2591105026","title":"三诺生物传感股份有限公司关于“三诺转债”2025年度付息公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2591105026","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591105026?lang=zh_cn&edition=full","pubTime":"2025-12-15 18:24","pubTimestamp":1765794275,"startTime":"0","endTime":"0","summary":"中访网数据 三诺生物传感股份有限公司于近日发布公告，其发行的可转换公司债券“三诺转债”将进行第五年付息。付息债权登记日定为2025年12月19日，付息日与除息日均为2025年12月22日。本次计息期间为2024年12月21日至2025年12月20日，票面利率为1.80%。本次付息完成后，“三诺转债”下一付息年度的票面利率将调整为2.00%。公司此次付息事宜委托中国结算深圳分公司办理。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251215/31866581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0114","BK0251","300298","BK0102"],"gpt_icon":0},{"id":"2590583008","title":"三诺生物：不向下修正转股价格","url":"https://stock-news.laohu8.com/highlight/detail?id=2590583008","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590583008?lang=zh_cn&edition=full","pubTime":"2025-12-10 18:06","pubTimestamp":1765361170,"startTime":"0","endTime":"0","summary":"证券之星消息，三诺生物12月10日在投资者关系平台上答复投资者关心的问题。感谢您对三诺生物的关注！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000029457.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","300298","BK0251","BK0102"],"gpt_icon":0},{"id":"2589435100","title":"三诺生物：公司将积极拓展境内外业务布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2589435100","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589435100?lang=zh_cn&edition=full","pubTime":"2025-12-08 22:09","pubTimestamp":1765202940,"startTime":"0","endTime":"0","summary":"证券日报网讯12月8日，三诺生物在互动平台回答投资者提问时表示，公司将积极拓展境内外业务布局。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-08/doc-inhachkv3625560.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-08/doc-inhachkv3625560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0114","BK0102","BK0251","300298"],"gpt_icon":0},{"id":"2589339170","title":"三诺生物：海牙法院批准雅培一项临时禁令","url":"https://stock-news.laohu8.com/highlight/detail?id=2589339170","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589339170?lang=zh_cn&edition=full","pubTime":"2025-12-08 18:00","pubTimestamp":1765188043,"startTime":"0","endTime":"0","summary":"雅培宣称公司生产的GlucoMen iCan CGM产品侵犯其专利权。2025年9月3日，海牙UPC分院开庭审理了两项申请，公司向UPC法庭递交了相关证据资料，否认有任何侵权行为并提出了不侵权和雅培该两项专利无效的抗辩。2025年10月17日，海牙UPC分院批准了雅培针对EP4344633的临时禁令申请。公司根据相关法律已经提起上诉，申请撤销针对EP4344633的临时禁令。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800022869.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300298","BK0102","BK0114"],"gpt_icon":0},{"id":"2589339954","title":"三诺生物：第二代CGM产品获欧盟MDR认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2589339954","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589339954?lang=zh_cn&edition=full","pubTime":"2025-12-08 17:54","pubTimestamp":1765187649,"startTime":"0","endTime":"0","summary":"公司第二代CGM产品已先后于2024年12月取得国家药品监督管理局颁发的III类医疗器械注册证，于2025年7月获得欧盟MDR认证。关于何时提交CGM新产品在美国FDA的注册申请，公司将基于之前FDA的反馈和注册经验，以及公司的产品布局策略，继续完善该系列产品的相关试验研究工作并通过FDA必要审核程序后及时启动申报工作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800022704.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["FESXmain","BK0114","BK0102","FSXEmain","BK0251","300298"],"gpt_icon":0},{"id":"2588059968","title":"三诺生物（300298）披露关于回购公司部分股份的进展公告，12月02日股价下跌0.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588059968","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588059968?lang=zh_cn&edition=full","pubTime":"2025-12-02 22:19","pubTimestamp":1764685146,"startTime":"0","endTime":"0","summary":"截至2025年12月2日收盘，三诺生物报收于17.75元，较前一交易日下跌0.73%，最新总市值为99.45亿元。该股当日开盘17.88元，最高17.88元，最低17.73元，成交额达5395.14万元，换手率为0.67%。近日，三诺生物传感股份有限公司发布关于回购公司部分股份的进展公告。公告显示，公司于2025年2月20日审议通过回购股份方案，拟使用自有资金及银行专项贷款，以集中竞价交易方式回购股份，用于员工持股计划、股权激励或转换可转债。回购符合既定方案及相关法律法规要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200039673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0251","300298","BK0102"],"gpt_icon":0},{"id":"2588037252","title":"三诺生物为控股子公司心诺健康提供4300万元贷款担保","url":"https://stock-news.laohu8.com/highlight/detail?id=2588037252","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588037252?lang=zh_cn&edition=full","pubTime":"2025-12-02 19:39","pubTimestamp":1764675562,"startTime":"0","endTime":"0","summary":"中访网数据 三诺生物传感股份有限公司于近日发布公告，披露了为控股子公司长沙心诺健康产业投资有限公司提供担保的进展。作为风险控制措施，被担保人心诺健康已向三诺生物提供同等金额的反担保。公司表示，心诺健康经营稳定，资信状况良好，担保风险可控。截至目前，三诺生物及控股子公司的实际担保总余额占公司最近一期经审计净资产的4.30%，且不存在对合并报表外单位的担保及逾期担保情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251202/31839236.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0102","300298","BK0114","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1767783234809,"stockEarnings":[{"period":"1week","weight":0.0344},{"period":"1month","weight":0.0219},{"period":"3month","weight":-0.1109},{"period":"6month","weight":-0.2173},{"period":"1year","weight":-0.2486},{"period":"ytd","weight":0.0357}],"compareEarnings":[{"period":"1week","weight":0.0299},{"period":"1month","weight":0.0463},{"period":"3month","weight":0.0517},{"period":"6month","weight":0.1635},{"period":"1year","weight":0.2734},{"period":"ytd","weight":0.0289}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"三诺生物传感股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"24597人(较上一季度增加58.52%)","perCapita":"18347股","listingDate":"2012-03-19","address":"湖南省长沙市岳麓区高新技术产业开发区谷苑路265号","registeredCapital":"56026万元","survey":" 三诺生物传感股份有限公司的主营业务是血糖监测系统的生产和销售。公司的主要产品是血糖监测系统。公司作为血糖监测领域领先企业，相继获得国内外权威机构的高度认可和荣誉。荣获“国家企业技术中心”、“国家工程研究中心”、“国家技术创新示范企业”、“国家知识产权优势企业”、“国家科技进步二等奖”和“国家绿色工厂”等资质。","listedPrice":29},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三诺生物(300298)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三诺生物(300298)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三诺生物,300298,三诺生物股票,三诺生物股票老虎,三诺生物股票老虎国际,三诺生物行情,三诺生物股票行情,三诺生物股价,三诺生物股市,三诺生物股票价格,三诺生物股票交易,三诺生物股票购买,三诺生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三诺生物(300298)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三诺生物(300298)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}